Suchergebnisse - (Person:"Mo, Hongnan")

PubPharm (5)

1

Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer : A prospective study

enthalten in: Thoracic cancer | 2024

von Wu, Y. | Mo, H. | Xu, H. | +4

2

Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer : A phase II trial

enthalten in: Breast (Edinburgh, Scotland) | 2023

von He, M. | Liu, J. | Wang, Z. | +11

3

Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies : real-world data in the Han population

enthalten in: Chinese medical journal | 2022

von Mo, H. | Ma, F. | Li, Q. | +7

4

Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer : A study of the National Cancer Center, China

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Li, Y. | Mo, H. | Guan, X. | +14

5

Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China

enthalten in: Breast (Edinburgh, Scotland) | 2021

von Li, Y. | Li, Q. | Mo, H. | +16

1
[1]